Legend Biotech (LEGN) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free LEGN Stock Alerts $47.12 -1.71 (-3.50%) (As of 04:35 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Legend Biotech Short Interest DataCurrent Short Volume9,990,000 sharesPrevious Short Volume10,510,000 sharesChange Vs. Previous Month-4.95%Dollar Volume Sold Short$560.34 millionShort Interest Ratio / Days to Cover10.2Last Record DateMarch 31, 2024Outstanding Shares181,910,000 sharesPercentage of Shares Shorted5.49%Today's Trading Volume816,005 sharesAverage Trading Volume992,269 sharesToday's Volume Vs. Average82% Short Selling Legend Biotech ? Sign up to receive the latest short interest report for Legend Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLEGN Short Interest Over TimeLEGN Days to Cover Over TimeLEGN Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Legend Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20249,990,000 shares $560.34 million -5.0%N/A10.2 $56.09 3/15/202410,510,000 shares $672.85 million +2.4%N/A10.8 $64.02 2/29/202410,260,000 shares $668.54 million +3.2%N/A11.1 $65.16 2/15/20249,940,000 shares $567.08 million -1.1%N/A9.7 $57.05 1/31/202410,050,000 shares $553.35 million +0.4%N/A9.8 $55.06 1/15/202410,010,000 shares $608.31 million +0.7%N/A10.4 $60.77 Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/20239,940,000 shares $598.09 million -7.4%N/A11.5 $60.17 12/15/202310,730,000 shares $657.64 million -0.2%N/A13 $61.29 11/30/202310,750,000 shares $653.82 million +21.1%N/A14.2 $60.82 11/15/20238,880,000 shares $576.93 million +9.2%N/A15.7 $64.97 10/31/20238,130,000 shares $537.15 million -0.4%N/A16.1 $66.07 10/15/20238,160,000 shares $542.64 million +4.8%N/A16.1 $66.50 9/30/20237,790,000 shares $523.25 million +8.0%N/A14.7 $67.17 9/15/20237,210,000 shares $478.38 million -2.8%N/A13.4 $66.35 8/31/20237,420,000 shares $514.65 million +7.2%N/A12.1 $69.36 8/15/20236,920,000 shares $463.29 million +1.6%N/A10 $66.95 7/31/20236,810,000 shares $514.29 million +15.8%N/A9.8 $75.52 7/15/20235,880,000 shares $408.42 million -1.5%N/A7.8 $69.46 6/30/20235,970,000 shares $412.11 million +5.9%N/A6.6 $69.03 6/15/20235,640,000 shares $401.85 million +24.5%N/A6.2 $71.25 5/31/20234,530,000 shares $290.69 million -3.2%N/A5.4 $64.17 5/15/20234,680,000 shares $342.30 million +13.6%N/A5.8 $73.14 4/30/20234,120,000 shares $283.09 million -21.4%N/A5.2 $68.71 4/15/20235,240,000 shares $277.82 million -11.2%N/A6.4 $53.02 3/31/20235,900,000 shares $284.50 million +15.5%N/A9.3 $48.22 3/15/20235,110,000 shares $239.71 million +14.8%N/A8.3 $46.91 2/28/20234,450,000 shares $205.50 million +12.7%N/A6.7 $46.18 2/15/20233,950,000 shares $192.96 million +7.1%N/A6 $48.85 1/31/20233,690,000 shares $186.35 million +0.8%N/A5.5 $50.50 1/15/20233,660,000 shares $209.97 million +1.7%N/A5.4 $57.37 12/30/20223,600,000 shares $179.71 million -19.1%N/A5.2 $49.92 12/15/20224,450,000 shares $230.69 million +13.2%N/A6.4 $51.84 11/30/20223,930,000 shares $202.43 million +6.5%N/A5.4 $51.51 11/15/20223,690,000 shares $193.73 million -38.7%N/A5.2 $52.50 10/31/20226,020,000 shares $299.92 million -13.0%N/A8.6 $49.82 10/15/20226,920,000 shares $275.07 million +2.5%N/A8.7 $39.75 9/30/20226,750,000 shares $275.40 million +22.3%N/A8.8 $40.80 9/15/20225,520,000 shares $240.12 million +22.7%N/A7.3 $43.50 8/31/20224,500,000 shares $209.21 million +10.8%N/A6.1 $46.49 8/15/20224,060,000 shares $189.68 million +17.0%N/A5.6 $46.72Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story LEGN Short Interest - Frequently Asked Questions What is Legend Biotech's current short interest? Short interest is the volume of Legend Biotech shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 9,990,000 shares of LEGN short. Learn More on Legend Biotech's current short interest. What is a good short interest ratio for Legend Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEGN shares currently have a short interest ratio of 10.0. Learn More on Legend Biotech's short interest ratio. Which institutional investors are shorting Legend Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Legend Biotech: Goldman Sachs Group Inc., Citadel Advisors LLC, PEAK6 Investments LLC, Goldman Sachs Group Inc., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Legend Biotech's short interest increasing or decreasing? Legend Biotech saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 9,990,000 shares, a drop of 4.9% from the previous total of 10,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Legend Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Legend Biotech: Ascendis Pharma A/S (5.75%), Catalent, Inc. (4.15%), Intra-Cellular Therapies, Inc. (3.58%), Cerevel Therapeutics Holdings, Inc. (11.06%), Viking Therapeutics, Inc. (8.64%), United Therapeutics Co. (11.28%), Sarepta Therapeutics, Inc. (4.90%), Cytokinetics, Incorporated (13.33%), Jazz Pharmaceuticals plc (5.41%), Elanco Animal Health Incorporated (2.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Legend Biotech stock? Short selling LEGN is an investing strategy that aims to generate trading profit from Legend Biotech as its price is falling. LEGN shares are trading down $1.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Legend Biotech? A short squeeze for Legend Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEGN, which in turn drives the price of the stock up even further. How often is Legend Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEGN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ASND Short Squeeze CTLT Short Squeeze ITCI Short Squeeze CERE Short Squeeze VKTX Short Squeeze UTHR Short Squeeze SRPT Short Squeeze CYTK Short Squeeze JAZZ Short Squeeze ELAN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEGN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlace